Semi-Annual Consolidated Statement Of Income

Modalis Therapeutics Corporation - Filing #7591582

Concept 2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
Semi-annual consolidated statement of income
Statement of income
Ordinary profit (loss)
-780,483,000 JPY
-464,982,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
19,980,000 JPY
19,230,000 JPY
Selling, general and administrative expenses
130,049,000 JPY
129,412,000 JPY
Extraordinary income
JPY
485,881,000 JPY
Operating profit (loss)
-868,457,000 JPY
-477,318,000 JPY
Profit (loss) before income taxes
-780,483,000 JPY
20,899,000 JPY
Non-operating income
Interest income
27,000 JPY
27,000 JPY
Non-operating income
91,227,000 JPY
13,129,000 JPY
Income taxes - current
609,000 JPY
1,269,000 JPY
Income taxes - deferred
-5,397,000 JPY
1,927,000 JPY
Non-operating expenses
Interest expenses
2,331,000 JPY
JPY
Non-operating expenses
3,253,000 JPY
793,000 JPY
Income taxes
-4,788,000 JPY
3,196,000 JPY
Profit (loss)
-775,695,000 JPY
17,702,000 JPY
Extraordinary income
Profit (loss) attributable to owners of parent
-775,695,000 JPY
17,702,000 JPY
Other comprehensive income
Foreign currency translation adjustment
28,819,000 JPY
4,618,000 JPY
Other comprehensive income
28,819,000 JPY
4,618,000 JPY
Comprehensive income
-746,875,000 JPY
22,321,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-746,875,000 JPY
22,321,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.